Avricore Health Inc.
AVCR.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.40K | 20.70K | 302.40K | 1.02M | 876.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.40K | 20.70K | 302.40K | 1.02M | 876.20K |
| Cost of Revenue | 65.50K | 55.50K | 61.20K | 593.70K | 557.50K |
| Gross Profit | -38.20K | -34.80K | 241.30K | 421.40K | 318.80K |
| SG&A Expenses | 231.10K | 290.10K | 287.50K | 360.00K | 432.30K |
| Depreciation & Amortization | 1.00K | 800.00 | 800.00 | 700.00 | 500.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 297.60K | 346.40K | 349.50K | 954.40K | 990.30K |
| Operating Income | -270.30K | -325.70K | -47.00K | 60.80K | -114.10K |
| Income Before Tax | -275.40K | -331.80K | -53.90K | -509.00K | -131.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -275.40K | -331.80K | -53.90K | -509.00K | -131.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -275.40K | -331.80K | -53.90K | -509.00K | -131.30K |
| EBIT | -270.30K | -325.70K | -47.00K | 60.80K | -114.10K |
| EBITDA | -237.70K | -295.40K | -19.80K | 139.20K | -29.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 101.29M | 101.29M | 101.29M | 101.24M | 100.40M |
| Average Diluted Shares Outstanding | 101.29M | 101.29M | 101.29M | 101.24M | 100.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |